Interview on aminopeptidase A inhibitors: Fabrice Balavoine, Vice-President research and Development Quantum Genomics, Paris Previous Post (p) Webcast: November 12, 2018 Next Post (n) L'Hebdo des PME : Interview with Jean-Philippe Milon